Madrigal Pharmaceuticals, Inc.

MDGL US5588681057

💰
Capitalization
Mid-cap

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.

Annual Performance 1
2021 2022 2023 2024 2025
-23% 222% -19% 36% 2%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
268
🙍
Insiders
12
Person Price Shares Total Published Completed
Sibold William John
CEO
445.63
USD
7,279
Sold
3,243,741
USD
09/09/2025 09/09/2025
Sibold William John
CEO
401.00
USD
1,131
Sold
453,531
USD
21/08/2025 21/08/2025
Sibold William John
CEO
400.03
USD
6,485
Sold
2,594,225
USD
21/08/2025 21/08/2025
Kelley Shannon T
SR OFF
375.75
USD
190
Sold
71,393
USD
18/08/2025 18/08/2025
Kelley Shannon T
SR OFF
372.44
USD
252
Sold
93,855
USD
18/08/2025 18/08/2025
Kelley Shannon T
SR OFF
370.06
USD
84
Sold
31,085
USD
18/08/2025 18/08/2025
Kelley Shannon T
SR OFF
376.62
USD
42
Sold
15,818
USD
18/08/2025 18/08/2025
Kelley Shannon T
SR OFF
369.64
USD
126
Sold
46,575
USD
18/08/2025 18/08/2025
Kelley Shannon T
SR OFF
358.66
USD
458
Sold
164,266
USD
18/08/2025 18/08/2025
Kelley Shannon T
SR OFF
371.35
USD
84
Sold
31,193
USD
18/08/2025 18/08/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Madrigal Pharmaceuticals, Inc. to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
57% 16% 20% 35% 209% 1759% 2668%
Last 52W Low 52W High All-Time Low All-Time High β
436.28 267.56 458.66 267.56 458.66
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Friedman Paul A 66 99,597,718.79 1,509,056.35 03/04/2024 13/08/2025
Taub Rebecca 50 48,553,743.89 971,074.88 03/04/2024 12/08/2025
Bate Kenneth 32 18,995,765.69 593,617.68 01/04/2024 15/08/2025
Daly James M 19 13,593,755.86 715,460.83 01/04/2024 27/02/2025
Craves Fred B 27 12,196,033.40 451,704.94 14/05/2024 13/03/2025
Waltermire Robert E. 25 8,858,836.84 354,353.47 12/12/2023 05/03/2025
Sibold William John 5 8,374,007.59 1,674,801.52 09/09/2024 09/09/2025
Levy Richard S 11 6,087,038.01 553,367.09 01/04/2024 07/11/2024
Lynch Brian Joseph 8 2,031,774.00 253,971.75 29/11/2023 05/12/2023
Huntsman Carole 12 996,938.92 83,078.24 21/11/2024 03/03/2025
Dier Mardi 3 720,592.38 240,197.46 03/03/2025 10/03/2025
Kelley Shannon T 10 694,386.42 69,438.64 17/01/2025 18/08/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Connected Companies 3
Name ISIN Ticker
PROTARA THERAPEUTICS, INC. US74365U1079 TARA

3 the firms where the current insiders have executed transactions.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.